tiprankstipranks

New Portfolio - New Portfolio

zach & Tuna

New Portfolio
Individual Investor
Ranked #476,290 out of 775,923 TipRanks' Investors
Success Rate
39%
14 out of 36
profitable transactions
Average Return
-6.17%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 6.64%
6-Month Return▼ 6.98%
12-Month Return-
YTD Return▲ 1.49%
Total Return▲ 1.49%

Best Trade

Opened at
Closed at
Gain▲ 32.32%

Bio

mostly short term within a month trades.

Performance

43.22%0-43.22%
▲ 11.46%
▲ 5.06%
▲ 17.16%
May 2024
▼ 2.25%
▲ 3.53%
▼ 2.73%
Jun 2024
▲ 25.71%
▲ 1.21%
▲ 0.75%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 15.56%
Aug 2024
▲ 7.82%
▲ 2.10%
▼ 6.82%
Sep 2024
▲ 5.38%
▼ 0.89%
▲ 5.21%
Oct 2024
▲ 43.22%
▲ 5.96%
▲ 22.48%
Nov 2024
▲ 3.34%
▼ 1.56%
▼ 12.82%
Dec 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 11.46%▲ 5.06%▲ 17.16%
▼ 2.25%▲ 3.53%▼ 2.73%
▲ 25.71%▲ 1.21%▲ 0.75%
▼ 4.22%▲ 2.34%▼ 15.56%
▲ 7.82%▲ 2.10%▼ 6.82%
▲ 5.38%▼ 0.89%▲ 5.21%
▲ 43.22%▲ 5.96%▲ 22.48%
▲ 3.34%▼ 1.56%▼ 12.82%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
SMX Public Limited Company
0%
▼ 0.94%
3
Open
Dec 10, 2024
Mind Medicine
▼ 12.48%
3
Close
Dec 09, 2024
Uber Technologies
100%
▼ 11.73%
2
Buy
Dec 09, 2024
Fusion Fuel Green
0%
0.00%
1
Open
Dec 05, 2024
Heron Therapeutics
0%
▼ 8.14%
1
Open
Dec 05, 2024
Arrowhead Pharmaceuticals
▲ 16.33%
5
Close
Dec 04, 2024
iShares Russell 2000 Growth ETF
▲ 1.48%
2
Close
Dec 04, 2024
Zomedica Pharmaceuticals
▲ 0.78%
3
Close
Dec 02, 2024
FiscalNote Holdings
▲ 1.18%
2
Close
Dec 02, 2024
Ocugen
▼ 0.22%
2
Close
Dec 02, 2024
SPDR S&P 500 ETF Trust
▲ 3.26%
2
Close
Nov 22, 2024
CERo Therapeutics Holdings
▲ 3.32%
2
Close
Nov 22, 2024
Vigil Neuroscience Inc
▼ 15.90%
3
Close
Oct 16, 2024
Cybin
▼ 0.45%
2
Close
Oct 16, 2024
ATAI Life Sciences
▼ 21.94%
2
Close
Oct 16, 2024
COMPASS Pathways
▼ 17.69%
2
Close
Oct 16, 2024
Amazon
▼ 0.05%
2
Close
Jul 31, 2024
Eledon Pharmaceuticals
▲ 25.64%
2
Close
Jul 31, 2024
Acumen Pharmaceuticals
▼ 13.16%
2
Close
Jul 31, 2024
Taysha Gene Therapies
▼ 29.28%
3
Close
Jul 31, 2024